CCL21 and neoplasm: In addition to promoting CD93 expression in pMCs, the tumor also activates the CD93 pathway in pMCs because we found that C1q was responsible for CD93-mediated inhibition of CCL21 production by pMCs, and the C1q level was enhanced in both mice with lung tumors and lung tumor patients.